In:
Reviews on Recent Clinical Trials, Bentham Science Publishers Ltd., Vol. 15, No. 3 ( 2020-09-21), p. 164-177
Abstract:
In accordance with the scientific literature heavy alcohol consumption
( 〉 50g per day) represents a risk factor for several diseases development, including cancer. However,
the oncogenic role of light alcohol drinking ( 〈 12.5g per day) is still unknown. Objective: To assess the scientific knowledge about light alcohol consumption and the risk of malignancy
onset. Methods: To collect the scientific evidences regarding this topic the keywords “light alcohol drinking”,
“light alcohol consumption” and “cancer”, were used. Papers published during the last 15 years were analyzed, in order to select the most recent evidence. Meta-analyses with well-defined
levels of alcohol intake were included in the present review. Other studies that focused on biochemical, molecular and genetic aspects, as well as duplicate articles, were excluded. : Furthermore, a possible protective role of light alcohol consumption on the development of bladder,
kidney and ovarian cancer and Non Hodgkin Lymphoma was observed. Results: Twenty-nine large, meta-analyses were included in this review. Light alcohol drinking
was not associated with an increased risk of cancer occurrence, with the exception of breast and prostate cancer and melanoma. Conclusion: Light alcohol drinking was not associated with the development of several malignancies,
except for a light increase of melanoma, breast cancer in women and prostate cancer in men.
Type of Medium:
Online Resource
ISSN:
1574-8871
DOI:
10.2174/1574887115666200628143015
Language:
English
Publisher:
Bentham Science Publishers Ltd.
Publication Date:
2020
Permalink